Xanodyne Pharmaceuticals Inc. the manufacturer of Darvon, which is also known as Darvon N 100, and Darvocet, the brand version of the prescription pain drug propoxyphene, agreed to remove the drug from the United States market at the request of the Food and Drug Administration (“FDA”). The FDA has advised the generic manufacturers of propoxyphene-containing drugs of Xanodyne’s decision and asked that they too remove their products from the U.S. market.

Darvon and Darvocet cause irregular heart beats and other cardiac related illnesses including death. In the coming months, lawsuits will be filed against Xanodyne Pharmaceuticals Inc. as there is substantial data available which shows that Xanodyne Pharmaceuticals Inc. knew of the harmful effects of Darvon and Darvocet, yet allowed these drugs to remain on the market.

Back in 2008, the consumer advocacy group Public Citizen filed a lawsuit against the FDA alleging that the agency violated the law by failing to act on a petition filed in 2006, which urged the FDA to recall Darvocet, Darvon and other drugs containing propoxyphene from the market. According to Public Citizen’s lawsuit, since 1981 more than 2,000 accidental deaths have been linked to Darvon and Darvocet. The lawsuit also alleges that Darvon and Darvocet are physically addictive and are no more effective than other safer painkillers, like ibuprofen and acetaminophen.

In response to the allegations made in Public Citizen’s lawsuit, an FDA advisory initiated an investigation into the safety of Darvon and Darvocet. In early 2009, the advisory panel concluded that the dangers associated with Darvon and Darvocet outweigh the benefits and therefore the drugs should be recalled. The FDA is notifying health care professionals to refrain from prescribing propoxyphene to their patients. Similarly, the FDA is urging patients who are currently using the drugs to contact their health care professional as soon as possible to discuss switching to another pain management remedy.

Patients injured by the serious side effects associated with Darvon and/or Darvocet may be entitled to file a lawsuit seeking compensation for their injuries. With a Darvon or Darvocet lawsuit, injured patients may be able to collect compensation.

If you have taken either Darvon or Darvocet and would like to obtain more information on with filing a lawsuit, please contact one of our Darvocet attorneys. Filing a lawsuit may lead to substantial financial compensation for your pain and suffering due to Xanodyne Pharmaceuticals Inc.’s negligent behavior.

Contact our law firm today  for a free and confidential case evaluation from one of our experienced Darvon and Darvocet attorneys.

Published November 17, 2011 by